Adimab, LLC 4
4 · Adagio Therapeutics, Inc. · Filed Apr 1, 2022
Insider Transaction Report
Form 4
Adimab, LLC
10% Owner
Transactions
- Other
Common Stock
2022-03-03−1,158,089→ 26,687,906 total
Footnotes (1)
- [F1]In connection with the resignation of Dr. Tillman Gerngross from the Issuer's Board of directors, the Issuer repurchased 1,158,089 shares of restricted common stock from the Reporting Person for aggregate consideration of $2,316.18.